Medtronic, Inc. has the FDA’s approval to initiate the Feasibility of the Lone Atrial Fibrillation Clinical Trial (FACT) ...
New tachycardia software for the Merlin Patient Care System by St. Jude Medical has received FDA approval. The software ...
The American College of Cardiology Foundation’s National Cardiovascular Data Registry (NCDR) says it will launch a new ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
An initial review of the premarket approval application for the ATS 3f(R) Aortic Bioprosthesis Heart Valve has been ...
Thoratec has announced it has filed the first two modules of its Pre-Market Approval to market its HeartMate II for ...
The first patient of the PATRIOT (Peripheral Approach To Recanalization In Occluded Totals) U.S. pivotal study has been ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
An aspirin a day really does keep heart attack and stroke away for women, yet fewer than half of American women who could benefit from the simple measure do not take a daily pill, according to recent research.
The FDA has cleared Boston Scientific’s NexStent Carotid Stent and Monorail Delivery System for use in patients with ...
San Francisco-based McKesson announced it has agreed to purchase Per-Se Technologies, Alpharetta, Ga., in a deal worth $1.8 billion. The purchase is expected to close in the first quarter of 2007 if it meets regulatory approval.
Behavioral science is being applied in unique ways for enterprise imaging product design. Involving clinicians in the ...
Stereotaxis has received FDA 510(k) clearance for its Niobe magnetic navigation system for use in neurovascular and ...
Hospitals and other medical facilities across the state of Washington will receive $1 million in grant money allocated ...
A dedicated interventional cardiology track is slated during the 2006 Scientific Sessions of the AHA in Chicago that ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
The FDA has approved NitroMist (Nitroglycerin Lingual Aerosol) for acute relief of an attack or acute prophylaxis of ...
Washington University surgeons at Barnes-Jewish Hospital, St. Louis, began training at UMC in Tucson on Nov. 2 to become ...
Results from the Phase II MEND-CABG study — which looked at demonstrated the clinical benefits of MC-1 in reducing ...